/

Serif Biomedicines

Developing modified DNA therapeutics for complex diseases.

BiotechnologyPharmaceuticals serifbiomedicines.com ↗

Company facts

Founded: 2021
Employees: 50
Headquarters: United States
Type: Private
Funding: Series A · $50M · 2026